# A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China

> **NCT07450170** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 3485 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07450170
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-10
- **Primary completion:** 2026-03-23
- **Final completion:** 2026-03-23
- **Target enrollment:** 3485 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07450170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07450170, "A Real-World Study of Omalizumab Treatment Patterns in Chronic Urticaria Patients in China". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07450170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*